atg-027,atg-101,atg-031,atg-018
antengene
['antengene']
antengene announced that it has presented posters from preclinical studies of four pipeline assets, atg-031, atg-101, atg-018, and atg-027 at the 37th society for immunotherapy of cancer annual meeting (sitc 2022).
read more: 